Search Results - "CHEMIN, I"

Refine Results
  1. 1

    Hepatitis B virus induced hepatocellular carcinoma by Chemin, I, Zoulim, F

    Published in Cancer letters (01-12-2009)
    “…Abstract A number of risk factors appear to play a role in Hepatocellularcinoma (HCC), HBV infection being one of the most important. Chronic inflammation and…”
    Get full text
    Journal Article
  2. 2

    Common dysregulation of Wnt Frizzled receptor elements in human hepatocellular carcinoma by Bengochea, A, de Souza, M M, Lefrançois, L, Le Roux, E, Galy, O, Chemin, I, Kim, M, Wands, J R, Trepo, C, Hainaut, P, Scoazec, J-Y, Vitvitski, L, Merle, P

    Published in British journal of cancer (08-07-2008)
    “…Dysregulation of growth factors and their receptors is central to human hepatocellular carcinoma (HCC). We previously demonstrated that the Frizzled-7 membrane…”
    Get full text
    Journal Article
  3. 3

    Clinical impact of occult HBV infections by Chemin, I., Trépo, C.

    Published in Journal of clinical virology (01-12-2005)
    “…HBV infection in the absence of HBsAg has been a matter of debate for years, but its existence and clinical relevance are now supported by many publications,…”
    Get full text
    Journal Article Conference Proceeding
  4. 4
  5. 5

    Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries by Ghosh, S., Sow, A., Guillot, C., Jeng, A., Ndow, G., Njie, R., Toure, S., Diop, M., Mboup, S., Kane, C. T., Lemoine, M., Thursz, M., Zoulim, F., Mendy, M., Chemin, I.

    Published in Journal of viral hepatitis (01-11-2016)
    “…Summary Hepatitis B virus (HBV) is a major cause of chronic liver disease worldwide. HBV infection is diagnosed by serological tests, while real‐time…”
    Get full text
    Journal Article
  6. 6

    Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C by Mrani, S., Chemin, I., Menouar, K., Guillaud, O., Pradat, P., Borghi, G., Trabaud, M.A., Chevallier, P., Chevallier, M., Zoulim, F., Trépo, C.

    Published in Journal of medical virology (01-08-2007)
    “…Occult hepatitis B virus (HBV) infection is common in chronic hepatitis C patient. However, its significance and consequences are still unclear. The aim of…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Recommendations for ICT use in Alzheimer’s disease assessment: Monaco CTAD expert meeting by Robert, Philippe H, Konig, A, Andrieu, S, Bremond, F, Chemin, I, Chung, P. C, Dartigues, J. F, Dubois, B, Feutren, G, Guillemaud, R, Kenisberg, P. A, Nave, S, Vellas, B, Verhey, F, Yesavage, J, Mallea, P

    “…Alzheimer disease (AD) and other related dementia represent a major challenge for health care systems within the aging population. It is therefore important to…”
    Get full text
    Journal Article Conference Proceeding
  10. 10
  11. 11
  12. 12
  13. 13

    Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy by Khattab, E., Chemin, I., Vuillermoz, I., Vieux, C., Mrani, S, Guillaud, O, Trepo, C., Zoulim, F.

    Published in Journal of clinical virology (01-06-2005)
    “…Occult hepatitis B virus (HBV) infection is characterized by the presence of HBV DNA in the absence of hepatitis B surface antigen (HBsAg) in the patient…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Role of silent hepatitis B virus in chronic hepatitis B surface antigen(−) liver disease by Chemin, I, Jeantet, D, Kay, A, Trépo, C

    Published in Antiviral research (01-11-2001)
    “…Despite a number of studies documenting hepatitis B virus (HBV) infection in the absence of hepatitis B surface antigen (HBsAg) a causal relationship between…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver by ROBACZEWSKA, M, GUERRET, S, COVA, L, REMY, J-S, CHEMIN, I, OFFENSPERGER, W-B, CHEVALLIER, M, BEHR, J-P, PODHAJSKA, A. J, BLUM, H. E, TREPO, C

    Published in Gene therapy (01-06-2001)
    “…Antisense oligodeoxynucleotides (ODNs) appear as attractive anti-hepatitis B virus (HBV) agents. We investigated in vivo, in the duck HBV (DHBV) infection…”
    Get full text
    Journal Article
  17. 17

    Liver-directed gene transfer: a linear polyethylenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo by Chemin, I., Moradpour, D., Wieland, S., Offensperger, W. -B., Walter, E., Behr, J. - P., Blum, H. E.

    Published in Journal of viral hepatitis (01-11-1998)
    “…Efficient DNA delivery is a prerequisite for the successful implementation of molecular antiviral strategies against chronic viral hepatitis and gene therapy…”
    Get full text
    Journal Article
  18. 18

    Use of a TT virus ORF1 recombinant protein to detect anti-TT virus antibodies in human sera by Ott, Catherine, Duret, Laurent, Chemin, Isabelle, Trepo, Christian, Mandrand, Bernard, Komurian-Pradel, Florence

    Published in Journal of general virology (01-12-2000)
    “…Unité Mixte de Recherche 2142 CNRS-bioMérieux, Ecole Normale Supérieure de Lyon, 46 Allée d’Italie, 69364 Lyon Cedex 07, France 1 Laboratoire de Biométrie…”
    Get full text
    Journal Article
  19. 19

    Double hepatitis B virus infection in a patient with HIV/hepatitis C virus coinfection and 'anti-hBc alone' as serological pattern by WAGNER, A. A, LOUSTAUD-RATTI, V, CHEMIN, I, WEINBRECK, P, DENIS, F, ALAIN, S

    “…Reported here is a case of double hepatitis B virus (HBV) infection in an HIV/hepatitis C virus (HCV)-coinfected patient with antibodies against hepatitis B…”
    Get full text
    Journal Article
  20. 20